{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:52:16Z","timestamp":1756993936065},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"vor","delay-in-days":19848,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[1961,9]]},"abstract":"<jats:p>Vanillic acid diethylamide, a respiratory stimulant, was injected intravenously in doses of 0.5 to 2 mg. per kilogram. Effects were noted within 30 seconds; they lasted approximately 10 minutes. There was an average increase in tidal respiratory volume of 48 per cent and in respiratory rate of 24 per cent. Electroencephalograms were made bejore and after administration. The drug led to diminution of alpha activity, scattered high voltage spikes, cerebral dysrhythmias, and in 1 patient a tonic seizure. There were no significant changes in pulse rate or blood pressure.<\/jats:p>","DOI":"10.1002\/cpt196125689","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:36:04Z","timestamp":1451954164000},"page":"689-691","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacologic effects of intravenous vanillic acid diethylamide in man"],"prefix":"10.1111","volume":"2","author":[{"given":"Murray J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Marvin","family":"Hand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Antrim","family":"Crellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,4]]},"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt196125689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt196125689","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt196125689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:33:13Z","timestamp":1699363993000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt196125689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1961,9]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1961,9]]}},"alternative-id":["10.1002\/cpt196125689"],"URL":"https:\/\/doi.org\/10.1002\/cpt196125689","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1961,9]]}}}